Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Pharmosa Biopharm Inc. (6875) Financial Statements

Pharmosa Biopharm Inc. Financial Overview

Pharmosa Biopharm Inc.'s market cap is currently NT$3.24B. The company's EPS TTM is NT$-2.73; its P/E ratio is -9.12; Pharmosa Biopharm Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Mar 23Dec 21
Income Statement
Total RevenueNT$ 67.27MNT$ 167.57MNT$ 314.50MNT$ 0.00NT$ 0.00
Gross ProfitNT$ -15.75MNT$ 126.90MNT$ 314.50MNT$ 0.00NT$ 0.00
Operating IncomeNT$ -402.86MNT$ -218.57MNT$ -2.82MNT$ -265.86MNT$ -255.26M
EBITDANT$ -371.37MNT$ -140.38MNT$ 34.63MNT$ -257.08MNT$ -244.13M
Net IncomeNT$ -383.85MNT$ -166.65MNT$ 8.46MNT$ -266.51MNT$ -256.48M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 1.13BNT$ 1.62BNT$ 974.06MNT$ 672.51MNT$ 461.46M
Total AssetsNT$ 1.75BNT$ 2.16BNT$ 1.33BNT$ 799.37MNT$ 586.37M
Total DebtNT$ 99.61MNT$ 117.60MNT$ 144.37MNT$ 21.19MNT$ 37.09M
Net DebtNT$ -531.62MNT$ -631.84MNT$ -829.69MNT$ -651.32MNT$ -424.37M
Total LiabilitiesNT$ 190.57MNT$ 225.66MNT$ 195.99MNT$ 38.25MNT$ 54.93M
Stockholders' EquityNT$ 1.56BNT$ 1.94BNT$ 1.14BNT$ 761.12MNT$ 531.43M
Cash Flow
Free Cash FlowNT$ -476.83MNT$ -293.13MNT$ -39.05MNT$ -268.50MNT$ -240.75M
Operating Cash FlowNT$ -357.48MNT$ -127.16MNT$ 42.42MNT$ -258.31MNT$ -237.51M
Investing Cash FlowNT$ 256.17MNT$ -1.04BNT$ -93.84MNT$ -10.17MNT$ 4.75M
Financing Cash FlowNT$ -16.89MNT$ 942.11MNT$ 352.97MNT$ 479.52MNT$ 279.68M

Currency in TWD

Pharmosa Biopharm Inc. Earnings and Revenue History

-800M-400M0400M-600 %-300 %0 %300 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

Pharmosa Biopharm Inc. Liabilities to Assets

0800M1.6B2.4B0 %10 %20 %30 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

Pharmosa Biopharm Inc. Cash Flow

-1.5B-1B-500M0500M1B1.5B2019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

Pharmosa Biopharm Inc. Forecast EPS vs Actual EPS

-1.2-1-0.8-0.6-0.4-0.2Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26EPS EstimateBeatMiss
Earnings >